Hastings Carl W

Avg. Two Year Performance

48% Avg. Purchase Return
22% Compound
22% Avg. Sale Return
11% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return16%15%3%< 1%48%
Purchase Success Rate2 of 44 of 43 of 42 of 42 of 4
Average Sale Return(1%)15%9%(3%)22%
Sale Success Rate2 of 43 of 43 of 43 of 43 of 4

Reliv International, Inc.

Drugs » Drug Manufacturers - Other

Chief Scientific Officer, Director:

Holdings: 598.79K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--